Beilinson Hospital gets $34 million donation, largest gift in Israel’s history, for cancer research

Renee Ghert-Zand is a reporter and feature writer for The Times of Israel.

Illustrative: Beilinson Hospital at the Rabin Medical Center in Petah Tikva in 2007 (Wikimedia Commons/Public Domain)
Illustrative: Beilinson Hospital at the Rabin Medical Center in Petah Tikva in 2007 (Wikimedia Commons/Public Domain)

Beilinson Hospital of the Rabin Medical Center has received a $34 million donation to fund integrative cancer research. The gift is the largest of its kind in Israel’s history.

Philanthropists Dr. Susan and Dr. Henry Samueli, the California-based co-founder and chairman of Broadcom, Inc. (a designer, developer, manufacturer, and global supplier of semiconductors and infrastructure software products) are giving $25 million to establish the Samueli Integrative Cancer Pioneering Institute. Clalit Health Services, Israel’s largest healthcare provider caring for 5 million patients, has donated an additional $9 million for the institute.

The institute aims to bridge the gaps between biological research, the hospital, and the community.

“We thank the Samuelis for this generous donation which will enable us to find a cure for cancer that impacts millions of people around the world,” said Beilinson Hospital CEO Dr. Eytan Wirtheim. “The Institute is keen to form partnerships and collaborations with the global cancer community, including academia, health organizations, industry and foundations – to transform cancer care and create a new future for cancer patients.”

Infrastructure development has begun for the Samueli Institute, which will comprise experts in behavioral sciences, cancer scientists, data scientists, artificial intelligence experts.

“We expect the Institute…to challenge existing care paradigms and create a better future for cancer patients inside of Israel and beyond,” Dr. Susan and Dr. Henry Samueli said in a statement.

Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure:
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.